Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04602221
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2020-10-16
Brief Title:
A Study in Healthy Men to Test Whether BI 409306 BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
A Randomized Placebo Controlled Double-blind Double-dummy Three-way Cross Over Trial to Investigate the Effect of BI 409306 BI 425809 and Lamotrigine on Ketamine-induced Cognitive Deficits in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objective of this trail is to investigate if and to what extent BI 409306 BI 425809 and lamotrigine attenuate ketamine induced cognitive deficits
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None